Glycemic Control and Excess Mortality in Type 1 Diabetes
NU Hospital Group · University of Gothenburg · +8 more institutions
Abstract
The excess risk of death from any cause and of death from cardiovascular causes is unknown among patients with type 1 diabetes and various levels of glycemic control. We conducted a registry-based observational study to determine the excess risk of death according to the level of glycemic control in a Swedish population of patients with diabetes.
We included in our study patients with type 1 diabetes registered in the Swedish National Diabetes Register after January 1, 1998. For each patient, five controls were randomly selected from the general population and matched according to age, sex, and county. Patients and controls were followed until December 31, 2011, through the Swedish Register for Cause-Specific Mortality.
Citation impact
- FWCI
- 53.95
- Percentile
- 100%
- References
- 31
Authors
9Topics & keywords
- Medicine
- Hazard ratio
- Glycemic
- Diabetes mellitus
- Glycated hemoglobin
- Type 2 diabetes
- Internal medicine
- Cause of death
- Good health and well-being
Funding
- ELEli Lilly and Company
- PPfizer
- AAstraZeneca
- SSanofi
- GSGilead Sciences
- ELEdwards Lifesciences
- VGVästra Götalandsregionen
- RPRegeneron Pharmaceuticals
- DDexcom
- NNNovo Nordisk
- VVetenskapsrådetAwards: 2013-4236, 2013-5187
- SLSvenska Läkaresällskapet
- GGenentech
- HAHealth and Medical Care Committee of the Regional Executive Board, Region Västra Götaland